PopED: An extended, parallelized, nonlinear mixed effects models optimal design toolJoakim Nyberg, Andrew C. Hooker, Sebastian Ueckert et al.|Computer Methods and Programs in Biomedicine|2012Cited by 86
P1–351: A novel BACE inhibitor (PF‐05297909): A two‐part adaptive design to evaluate safety, pharmacokinetics and pharmacodynamics for modifying beta‐amyloid in a first‐in‐human studyJ. Simon Bell, Timothy Nicholas, Brian T. O’Neill et al.|Alzheimer s & Dementia|2013Cited by 10
Optimizing disease progression study designs for drug effect discriminationSebastian Ueckert, Andrew C. Hooker, Stefanie Hennig et al.|Journal of Pharmacokinetics and Pharmacodynamics|2013Cited by 7
Handling Below Limit of Quantification Data in Optimal Trial DesignCamille Vong, Andrew C. Hooker, Joakim Nyberg et al.|Journal of Pharmacokinetics and Pharmacodynamics|2014Cited by 5
PopED: Population (and Individual) Optimal Experimental DesignAndrew C. Hooker, Joakim Nyberg, Marco Foracchia et al.|Unknown|2014Cited by 0